(Translated by https://www.hiragana.jp/)
Drugs.com - Prescription Drug Information Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Hympavzi (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors

(BUSINESS WIRE) October 11, 2024 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab-hncq)...

FDA Approves Itovebi (inavolisib) for the Combination Treatment of Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation

October 10, 2024 -- Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) approved Itovebi (inavolisib),...

Data presented from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis

AUSTIN, Texas, Oct. 12, 2024 . Aileron Therapeutics, Inc. ("Aileron"), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines...

Choosing the Right Rehab for Yourself or a Loved One

You've broken a hip and rehabilitation is part of the way back to mobility, or your partner has suffered a stroke and needs help re-learning certain skills. These...

Letter Nudges Increase Likelihood of Flu Vaccination for Adults With Chronic Diseases

For patients aged 18 to 64 years with chronic diseases, electronically delivered letter nudges increase influenza vaccination rates compared with usual...

Medical Financial Hardships Shared in Cancer-Linked Crowdfunding Stories

A considerable proportion of cancer-related crowdfunding stories share experiences of medical financial hardships and health-related social needs (HRSNs),...

Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome

NEEDHAM, Mass., Oct. 11, 2024 /PRNewswire/ — Stealth BioTherapeutics Inc. (the “Company” or “Stealth”), a clinical-stage...

U.S. Scientists Awarded Nobel Prize in Medicine for Groundbreaking DNA Discovery

A pair of American scientists has been honored with the 2024 Nobel Prize in Medicine for their role in the groundbreaking discovery of microRNA—tiny...

Liberal Transfusion Strategy May Avert Unfavorable Neurological Outcome

For patients with acute brain injury, a liberal transfusion strategy is associated with a lower risk for having an unfavorable neurological outcome, according...

Hope for New Test, Treatment for Endometriosis

Endometriosis could be linked to the health of a woman’s microbiome, a new study says. The discovery might help lead to an early test for the painful...

IV Fluid Plant in Florida Remains Functional After Milton

Facing a nationwide shortage of vital IV fluids after Hurricane Helene knocked out a North Carolina production plant, officials heaved a sigh of relief...

2 Million Fisher-Price Infant Swings Recalled After 5 Deaths

The Fisher-Price company is recalling more than 2 million of its Snuga infant swings, after the suffocation and deaths of five infants who went to sleep...

Positive Top-line Results from Phase 3 Study of Effexor in Japanese Adults with Generalized Anxiety Disorder

PITTSBURGH and TOKYO, Oct. 9, 2024. Viatris Inc., a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367)...

U.S. Food and Drug Administration (FDA) Accepts New Drug Application for Elinzanetant

Berlin, October 9, 2024 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application...

Are People Holding Their Arms Incorrectly for Blood Pressure Tests?

Checking your blood pressure at home? Pay attention to arm position. A new study by Johns Hopkins researchers confirms that it makes a "huge difference"...

Read more news...

Recently Added

Recently added consumer and prescribing information: Flyrcado, Otulfi, Tecentriq Hybreza, Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Hympavzi Hympavzi (marstacimab-hncq) is a tissue factor pathway inhibitor (TFPI) antagonist used for the treatment of adults and adolescents with...
  • Itovebi Itovebi (inavolisib) is a phosphatidylinositol 3-kinase (PI3K) alpha inhibitor used for the combination treatment of PIK3CA-mutated...
  • Otulfi Otulfi (ustekinumab-aauz) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...

More drugs in development